5-Ethoxy-2-fluoro-4-iodopyridine

Catalog No.: 
ACLBFF488
CAS No.: 
1805067-47-3
Molecular Formula: 
C7H7FINO
Molecular Weight: 
267.04
5-Ethoxy-2-fluoro-4-iodopyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$192.00InquiryInquiry
250mg95%$363.00InquiryInquiry
1g95%$711.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Ethoxy-2-fluoro-4-iodopyridine
IUPAC Name5-ethoxy-2-fluoro-4-iodopyridine
MDL No.MFCD28795550
Molecular FormulaC7H7FINO
Molecular Weight267.04
SMILESIC1=CC(F)=NC=C1OCC
InChI KeyTVIKFXDXVPVOLL-UHFFFAOYSA-N
SynonymPyridine, 5-ethoxy-2-fluoro-4-iodo-
CAS No.1805067-47-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLBFF488 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUXLZ461 route compound structure diagram
    ACUXLZ4611034467-29-2In Stock
  4. Then
  5. ACLBFF488 route product structure diagram
    ACLBFF4881805067-47-3
Inquiry

2. ACLBFF488 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUXLZ461 route compound structure diagram
    ACUXLZ4611034467-29-2In Stock
  4. Then
  5. ACLBFF488 route product structure diagram
    ACLBFF4881805067-47-3
Inquiry

3. ACLBFF488 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACUXLZ461 route compound structure diagram
    ACUXLZ4611034467-29-2In Stock
  4. Then
  5. ACLBFF488 route product structure diagram
    ACLBFF4881805067-47-3
Inquiry

Comments (0)